Andreas Brown

Andreas Brown

Auto-generated profile, based on publicly available information

Andreas Brown

Ulm University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Cell Reports
Verified
Journal Article
Open access
BMBettina M. Moehrle
Bettina M. Moehrle
KNKalpana Nattamai
Kalpana Nattamai
ABAndreas Brown
Andreas Brown
Maria Carolina FlorianMaria Carolina Florian
Maria Carolina Florian
MRMarnie Ryan
Marnie Ryan
HGHartmut Geiger
Hartmut Geiger
Whether aged hematopoietic stem and progenitor cells (HSPCs) have impaired DNA damage repair is controversial. Using a combination of DNA mutation indicator assays, we observe a 2- to 3-fold increase in the number of DNA mutations in the hematopoietic system upon aging. Young and aged hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) do not show an increase in mutation upon irradiation-induced DNA damage repair, and young and aged HSPCs respond very similarly to DNA damage with respect to cell-cycle checkpoint activation and apoptosis. Both young and aged HSPCs show impaired activation of the DNA-damage-induced G1-S checkpoint. Induction of chronic DNA double-strand breaks by zinc-finger nucleases suggests that HSPCs undergo apoptosis rather than faulty repair. These data reveal a protective mechanism in both the young and aged hematopoietic system against accumulation of mutations in response to DNA damage.

1 May 2015 in Molecular Cell
Verified
Journal Article
Closed access
SHSusanne Hellmuth
Susanne Hellmuth
SRScott Rata
Scott Rata
ABAndreas Brown
Andreas Brown
SHStefan Heidmann
Stefan Heidmann
BNBela Novak
Bela Novak
OSOlaf Stemmann
Olaf Stemmann

1 March 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SHSusanne Hellmuth
Susanne Hellmuth
CPChristopher Pöhlmann
Christopher Pöhlmann
ABAndreas Brown
Andreas Brown
FBFranziska Böttger
Franziska Böttger
MSMathias Sprinzl
Mathias Sprinzl
OSOlaf Stemmann
Olaf Stemmann
Sister chromatid cohesion is established during replication by entrapment of both dsDNAs within the cohesin ring complex. It is dissolved in anaphase when separase, a giant cysteine endopeptidase, cleaves the Scc1/Rad21 subunit of cohesin, thereby triggering chromosome segregation. Separase is held inactive by association with securin until this anaphase inhibitor is destroyed at the metaphase-to-anaphase transition by ubiquitin-dependent degradation. The relevant ubiquitin ligase, the anaphase-promoting complex/cyclosome, also targets cyclin B1, thereby causing inactivation of Cdk1 and mitotic exit. Although separase is essential, securin knock-out mice are surprisingly viable and fertile. Capitalizing on our previous finding that Cdk1-cyclin B1 can also bind and inhibit separase, we investigated whether this kinase might be suitable to maintain faithful timing and execution of anaphase in the absence of securin. We found that, similar to securin, Cdk1-cyclin B1 regulates separase in both a positive and negative manner. Although securin associates with nascent separase to co-translationally assist proper folding, Cdk1-cyclin B1 acts on native state separase. Upon entry into mitosis, Cdk1-cyclin B1-dependent phosphorylation of Ser-1126 renders separase prone to inactivation by aggregation/precipitation. Stable association of Cdk1-cyclin B1 with phosphorylated separase counteracts this tendency and stabilizes separase in an inhibited yet activatable state. These opposing effects are suited to prevent premature cleavage of cohesin in early mitosis while ensuring timely activation of separase by anaphase-promoting complex/cyclosome-dependent degradation of cyclin B1. Coupling sister chromatid separation with subsequent exit from mitosis by this simplified mode might have been the common scheme of mitotic control prior to the evolution of securin.

1 March 2010 in Endocrine-Related Cancer
Verified
Journal Article
Open access
PDF file
KUKristian Unger
Kristian Unger
JWJohannes Wienberg
Johannes Wienberg
ARAndrew Riches
Andrew Riches
LHLudwig Hieber
Ludwig Hieber
AWAxel Walch
Axel Walch
Horst ZitzelsbergerHorst Zitzelsberger
Horst Zitzelsberger
Chromosomal copy number alterations and chromosomal rearrangements are frequent mutations in human cancer. Unlike copy number alterations, little is known about the role and occurrence of chromosomal rearrangements in breast cancer. This may be due to the fact that chromosome-based breakpoint analysis is widely restricted to cultured cells. In order to identify gene rearrangements in breast cancer, we studied the chromosomal breakpoints in radiation-transformed epithelial breast cell lines using a high-resolution array-based approach using 1 Mb bacterial artificial chromosome (BAC) arrays. The breakpoints were further narrowed down by fluorescence in situ hybridisation (FISH) with clones from the 32 k BAC library. The analysis of the cell lines B42-11 and B42-16 revealed rearrangements of chromosomes 7, 8, 10 and 12. We identified the genes Has2, Grid1, Ret, Cpm, Tbx3, Tbx5, Tuba1a, Wnt1 and Arf3 within the breakpoint regions. Quantitative RT-PCR showed a deregulated expression of all of these candidate genes except for Tbx5 and Tbx3. This is the first study demonstrating gene rearrangements and their deregulated mRNA expression in radiation-transformed breast cells. Since the gene rearrangements occurred in the transformed and tumourigenic cell lines only, it is likely that these were generated in conjunction with malignant transformation of the epithelial breast cells and therefore might reflect early molecular events in breast carcinogenesis. Initial studies indicate that these gene alterations are also found in sporadic breast cancers.

31 July 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
ABAndreas Brown
Andreas Brown
HGHartmut Geiger
Hartmut Geiger
Loss of chromosome integrity is a major contributor to cancer. Checkpoints within the cell division cycle that facilitate the accuracy and outcome of chromosome segregation are thus critical pathways for preserving chromosome integrity and preventing chromosomal instability. The spindle assembly checkpoint, the decatenation checkpoint and the post-mitotic tetraploidy checkpoint ensure the appropriate establishment of the spindle apparatus, block mitotic entry upon entanglement of chromosomes or prevent further progression of post-mitotic cells that display massive spindle defects. Most of our knowledge on these mechanisms originates from studies conducted in yeast, cancer cell lines and differentiated cells. Considering that in many instances cancer derives from transformed stem and progenitor cells, our knowledge on these checkpoints in these cells just started to emerge. With this review, we provide a general overview of the current knowledge of these checkpoints in embryonic as well as in adult stem and progenitor cells with a focus on the hematopoietic system and outline common mis-regulations of their function associated with cancer and leukemia. Most cancers are aging-associated diseases. We will thus also discuss changes in the function and outcome of these checkpoints upon aging of stem and progenitor cells.

1 November 2010 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MZMiroslava Zoldakova
Miroslava Zoldakova
ZKZsuzsanna Kornyei
Zsuzsanna Kornyei
ABAndreas Brown
Andreas Brown
BBBernhard Biersack
Bernhard Biersack
EMEmília Madarász
Emília Madarász
RSRainer Schobert
Rainer Schobert